login
login

Europe Daily Bulletin No. 8680

3 April 2004
Contents Publication in full By article 47 / 49
ECONOMIC INTERPENETRATION / (eu) biotechnology

In the United States, AMGEN has bought TULARIK (turnover of $30.7 million in 2003) for the sum of $1.3 billion in shares at 25 dollars per share.

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION